sábado, 10 de marzo de 2012

Women's Health, NIAID, NIH

Women's Health, NIAID, NIH

Women's Health

Women face unique health problems related to many of NIAID’s mission areas—specifically, HIV/AIDS, sexually transmitted diseases (STDs), and autoimmune disorders. Many infectious and autoimmune diseases affect female populations disproportionately. For example, genital herpes from herpes simplex virus 2 is nearly twice as common among women as among men. Likewise, women account for more cases of chlamydia, lupus, and scleroderma than do men.
Even diseases that strike men and women in nearly equal numbers may have unique consequences or complications for women. For instance, women with HIV are at higher risk of severe cases of gynecological problems, such as chlamydia or bacterial vaginosis, than are non-infected women. Women also risk passing some of these diseases to children during pregnancy or breastfeeding.

NIAID's Role in Women's Health

NIAID is committed to research that helps reduce the incidence and improve the treatment of infectious and autoimmune diseases affecting women. Its efforts have led to the development of better drugs for HIV/AIDS, rapid diagnostics for STDs, and initiatives funding research into the causes of autoimmune diseases that disproportionately affect women. Learn more about NIAID’s women’s health research and read the Women's Health Questions and Answers.
Listen to an interview with NIAID Director Anthony S. Fauci, M.D., on the breakthrough study in microbicides to prevent HIV infection.External Web Site Policy

No hay comentarios:

Publicar un comentario